Patents by Inventor Lindsey DeRatt

Lindsey DeRatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Publication number: 20240158414
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula I as follows: wherein R1, R2, R3, and Q are defined herein.
    Type: Application
    Filed: October 9, 2020
    Publication date: May 16, 2024
    Inventors: Justin Cisar, Scott Kuduk, Lindsey DeRatt, Yvan Rene Ferdinand Simonnet
  • Dihydroorotate dehydrogenase inhibitors
    Patent number: 11753393
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: September 12, 2023
    Inventors: Scott Kuduk, Zhuming Zhang, Lindsey DeRatt, Aihua Wang
  • Dihydroorotate dehydrogenase inhibitors
    Patent number: 11505536
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: November 22, 2022
    Inventors: Scott Kuduk, Zhuming Zhang, Lindsey DeRatt, Aihua Wang
  • SUBSTITUTED UREA DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Publication number: 20220298107
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula I as follows: wherein R1, R2, R3 and R6 are defined herein.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 22, 2022
    Inventors: Scott Kuduk, Lindsey DeRatt
  • DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Publication number: 20220298137
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.
    Type: Application
    Filed: May 12, 2022
    Publication date: September 22, 2022
    Inventors: Scott Kuduk, Zhuming Zhang, Lindsey DeRatt, Aihua Wang
  • DIHYDROOROTATE DEHYDROGENASE INHIBITORS
    Publication number: 20200331881
    Abstract: Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Inventors: Scott Kuduk, Zhuming Zhang, Lindsey DeRatt, Aihua Wang